Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Helsinn Therapeutics (U.S.), Inc.

Helsinn Therapeutics (U.S.), Inc. Patent applications
Patent application numberTitlePublished
20120077745Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues - The present invention relates to a method of stimulating the motility of the gastrointestinal system in a subject in need thereof, wherein the subject suffers from maladies (i.e., disorders or diseases) of the gastrointestinal system. The method comprises administering to a subject in need thereof a therapeutically effective amount of a growth hormone secretagogue compound or a pharmaceutically acceptable salt, hydrate or solvate thereof. The growth hormone secretagogue can be co-administered with a laxative, a H03-29-2012
20120010157Method of stimulating the motility of the gastrointestinal system using ipamorelin - The present invention provides a method of stimulating the motility of the gastrointestinal system in a subject in need thereof, wherein the subject suffers from maladies (i.e., disorders, diseases, conditions, or drug- or surgery-induced dysfunction) of the gastrointestinal system, by administering to the subject a ghrelin mimetic, or pharmaceutically acceptable salt thereof. The invention also provides a method of treating a gastrointestinal malady by co-administering a ghrelin mimetic with a laxative, a H01-12-2012
20110003996Crystal Forms of (3R)-1-(2-Methylalanyl-D-Tryptophyl)-3-(Phenylmethyl)-3-Piperidinecarboxy- lic Acid 1,2,2-Trimethylhydrazide - Crystalline polymorphs of (3R)-1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide which are useful as pharmaceutical agents are disclosed. Methods of production and isolation of these polymorphs and pharmaceutical compositions which include these polymorphs and pharmaceutical methods of treatment are also disclosed. The crystalline polymorphs of the present invention are useful as they act directly on the pituitary gland cells to release growth hormone.01-06-2011
20100317581Ipamorelin Diacetate Injection and Infusion Solutions - Injection and infusion solutions of ipamorelin, having the following composition: 12-16-2010
20100222388Enhanced Migraine Treatments Based on Ghrelin Mimetics - The present invention relates to method of enhancing the absorption of migraine medications and thereby treating migraines by co-administering to a subject in need thereof an effective amount of a ghrelin mimetic or pharmaceutically acceptable salt, hydrate or solvate thereof and at least one migraine medication selected from a serotonin 5-HT09-02-2010
20100087381Method of Stimulating the Motility of the Gastrointestinal System Using Growth Hormone Secretagogues - The present invention relates to a method of stimulating the motility of the gastrointestinal system in a subject in need thereof, wherein the subject suffers from maladies (i.e., disorders or diseases) of the gastrointestinal system. The method comprises administering to a subject in need thereof a therapeutically effective amount of a growth hormone secretagogue compound or a pharmaceutically acceptable salt, hydrate or solvate thereof. The growth hormone secretagogue can be co-administered with a laxative, a H04-08-2010

Patent applications by Helsinn Therapeutics (U.S.), Inc.